S. Kharitonov

发表

Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.

P. Montuschi, P. Barnes, M. Corradi, 1999, American journal of respiratory and critical care medicine.

Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis

Massimo Corradi, Paolo Montuschi, P. Montuschi, 2000, Thorax.

CT-guided pleural biopsy preferable to traditional Abram’s needle in diagnosing malignant pleural disease

P. Montuschi, P. Barnes, G. Ciabattoni, 2003, Thorax.

Exhaled 8-isoprostane in childhood asthma

P. Barnes, S. Kharitonov, S. Shahid, 2005, Respiratory research.

Analysis of expired air for oxidation products.

P. Barnes, S. Kharitonov, P. Paredi, 2002, American journal of respiratory and critical care medicine.

Repeatability of sodium and chloride in exhaled breath condensates

S. Kharitonov, N. Wilson, A. Bush, 2004, Pediatric pulmonology.

Exhaled markers of inflammation

P. Barnes, S. Kharitonov, 2001, Current opinion in allergy and clinical immunology.

Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis.

Giovanna E Carpagnano, D. Geddes, P. Barnes, 2003, American journal of respiratory and critical care medicine.

Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery.

M. Griffiths, S. Kharitonov, G. J. Quinlan, 2004, American journal of respiratory and critical care medicine.

Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis

P. Barnes, S. Kharitonov, M. Hodson, 2000, Thorax.

Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction.

P. Shah, P. Barnes, S. Kharitonov, 2000, American journal of respiratory and critical care medicine.

Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma.

Andrew Bush, Emmanouil Paraskakis, Caterina Brindicci, 2006, American journal of respiratory and critical care medicine.

Increased carbon monoxide in exhaled air of patients with cystic fibrosis

P. Montuschi, P. Shah, P. Barnes, 1999, Thorax.

Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.

D. Yates, P. Barnes, S. Kharitonov, 1996, American journal of respiratory and critical care medicine.

Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

P. Barnes, S. Kharitonov, A. Jatakanon, 1999, Thorax.

Exhaled carbon monoxide and nitric oxide in COPD.

P. Montuschi, P. Barnes, S. Kharitonov, 2001, Chest.

Pulmonary biomarkers in chronic obstructive pulmonary disease.

D. Postma, H. Magnussen, P. Barnes, 2006, American journal of respiratory and critical care medicine.

Normal bronchial blood flow in COPD is unaffected by inhaled corticosteroids and correlates with exhaled nitric oxide.

P. Barnes, S. Kharitonov, P. Paredi, 2007, Chest.

Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide.

D. Yates, P. Barnes, S. Kharitonov, 1995, American journal of respiratory and critical care medicine.

Non-invasive assessment of airway inflammation

I. Pavord, S. Kharitonov, 2009 .

Nitric Oxide in Exhaled Air: Relevance in Inflammatory Lung Disease

P. Barnes, S. Kharitonov, 2000 .

Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension.

R. D. du Bois, P. Barnes, S. Kharitonov, 1997, Thorax.

Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke

P. Barnes, S. Kharitonov, L. Donnelly, 2001, Thorax.

Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry

I. Horváth, O. Usmani, P. Barnes, 2013, BMC Pulmonary Medicine.

Increased inflammatory markers in the exhaled breath condensate of cigarette smokers

P. Barnes, O. Resta, M. Foschino-Barbaro, 2003, European Respiratory Journal.

Exhaled nitric oxide is increased in active fibrosing alveolitis.

R. D. du Bois, P. Barnes, S. Kharitonov, 1999, Chest.

Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma.

P. Barnes, S. Kharitonov, O. Basoglu, 2005, Chest.

Exhaled biomarkers.

P. Barnes, S. Kharitonov, 2006, Chest.

Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children

P. Barnes, S. Kharitonov, S. Meah, 2003, European Respiratory Journal.

Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis.

P. Barnes, S. Kharitonov, J. D. Antuni, 2000, The Journal of allergy and clinical immunology.

Chapter 30 – Nitric Oxide

S. Kharitonov, Kazuhiro Ito, 2009 .

Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.

K. Chung, P. Barnes, S. Kharitonov, 1998, Thorax.

Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections.

D. Yates, P. Barnes, S. Kharitonov, 1995, The European respiratory journal.

Measurement of Exhaled Nitric Oxide

S. Kharitonov, 2005 .

Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase.

D. Yates, P. Barnes, S. Kharitonov, 1996, American journal of respiratory and critical care medicine.

Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients.

P. Barnes, S. Kharitonov, Kazuhiro Ito, 2011, Respiratory medicine.

Airway responsiveness and inflammation in adolescent elite swimmers.

V. Backer, P. Barnes, S. Kharitonov, 2008, The Journal of allergy and clinical immunology.

Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity.

P. Barnes, S. Kharitonov, Kazuhiro Ito, 2007, Chest.

Exhaled carbon monoxide in patients with lower respiratory tract infection.

P. Barnes, S. Kharitonov, W. Biernacki, 2001, Respiratory medicine.

Exhaled carbon monoxide in childhood asthma.

P. Barnes, S. Kharitonov, N. Wilson, 1999, The Journal of pediatrics.

Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract.

K. Chung, P. Barnes, D. Evans, 1996, American journal of respiratory and critical care medicine.

Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients.

D. Yates, K. Chung, P. Barnes, 1996, The European respiratory journal.

Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide.

P. Barnes, D. Evans, B. O'connor, 1995, American journal of respiratory and critical care medicine.

Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease

P. Barnes, S. Kharitonov, 2003, Current allergy and asthma reports.

Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease.

P. Barnes, S. Kharitonov, 2004, Proceedings of the American Thoracic Society.

Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients.

P. Barnes, S. Kharitonov, Kazuhiro Ito, 2009, Chest.

Inflammatory Response to Sputum Induction Measured by Exhaled Markers

P. Montuschi, P. Barnes, S. Kharitonov, 2005, Respiration.

Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma.

P. Montuschi, P. Barnes, S. Kharitonov, 2002, American journal of respiratory and critical care medicine.

Measurement of exhaled hydrocarbons.

P. Barnes, S. Kharitonov, P. Paredi, 2001, Methods in molecular medicine.

Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma

P. Montuschi, P. Barnes, M. Corradi, 2002, Thorax.

Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers.

P. Barnes, S. Kharitonov, Kazuhiro Ito, 2007, Chest.

Correlation of exhaled breath temperature with bronchial blood flow in asthma

P. Barnes, S. Kharitonov, P. Paredi, 2005, Respiratory research.

Prostaglandins E2 and F2alpha reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes.

K. Chung, P. Barnes, S. Kharitonov, 1998, American journal of respiratory and critical care medicine.

Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids

S. Durham, P. Barnes, S. Kharitonov, 1997 .

Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients.

D. Yates, P. Barnes, S. Kharitonov, 1997, The European respiratory journal.

Formoterol attenuates neutrophilic airway inflammation in asthma.

I. Adcock, P. Barnes, S. Kharitonov, 2005, Chest.

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.

D. Yates, P. Barnes, S. Kharitonov, 1996, American journal of respiratory and critical care medicine.

Noninvasive assessment of airway inflammation in asthma

P. Barnes, S. Kharitonov, J. Kips, 2003 .

CHAPTER 9 Noninvasive assessment of airway inflammation in asthma

P. Barnes, S. Kharitonov, J. Kips, 2003 .

Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness.

I. Adcock, K. Chung, P. Barnes, 2002, European journal of pharmacology.

Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils.

I. Adcock, P. Barnes, S. Kharitonov, 2007, Chest.

Increased leukotrienes in exhaled breath condensate in childhood asthma.

P. Barnes, S. Kharitonov, N. Wilson, 2002, American journal of respiratory and critical care medicine.

Inflammatory Markers: Exhaled Nitric Oxide and Carbon Monoxide During the Ovarian Cycle

P. Barnes, S. Kharitonov, A. Antczak, 2011, Inflammation.

Repeatability of standardised nasal nitric oxide measurements in healthy and asthmatic adults and children.

P. Barnes, S. Kharitonov, L. Walker, 2005, Respiratory medicine.

Exhaled breath markers in COPD

P. Barnes, S. Kharitonov, 2004 .

Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia.

P. Barnes, S. Kharitonov, N. Wilson, 2003, Chest.

Prostaglandins mediate bradykinin-induced reduction of exhaled nitric oxide in asthma.

M. Sapienza, K. Chung, P. Barnes, 1999, The European respiratory journal.

Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis

P. Barnes, S. Kharitonov, S. Loukides, 1998, Thorax.

Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding.

P. Barnes, S. Kharitonov, Peter J. Barnes, 1997, Thorax.

Airway and cough responsiveness and exhaled nitric oxide in non-smoking patients with stable chronic heart failure.

K. Chung, T. Chua, A. Coats, 1996, Heart.

Feasibility and interpretation of FE(NO) measurements in asthma patients in general practice.

P. Barnes, S. Kharitonov, D. Olivieri, 2008, Respiratory medicine.

Does exhaled nitric oxide reflect asthma control? Yes, it does!

P. Barnes, S. Kharitonov, 2001, American journal of respiratory and critical care medicine.

Exhaled Breath Analysis

P. Barnes, S. Kharitonov, 2001 .

Measurement of exhaled nitric oxide and carbon monoxide.

S. Kharitonov, 2001, Methods in molecular medicine.

Exhaled nitric oxide is increased in asthma.

D. Yates, J. Polak, P. Barnes, 1995, Chest.

Chapter 44 – Noninvasive Assessment of Airway Inflammation

S. Kharitonov, 2002 .

Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle.

S. Kharitonov, R. Logan-Sinclair, E. Shinebourne, 1994, British heart journal.

Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids.

S. Durham, P. Barnes, S. Kharitonov, 1997, The Journal of allergy and clinical immunology.

Nitric Oxide-Derived Markers in Exhaled Breath Condensate

S. Kharitonov, 2004 .

Influence of different therapeutic strategies on exhaled NO and lung inflammation in asthma and COPD.

S. Kharitonov, 2005, Vascular pharmacology.

Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients.

H. Biernacka, P. Barnes, S. Kharitonov, 2005, Chest.

Exhaled Nitric Oxide and Hydrogen Peroxide Concentrations in Asthmatic Smokers

I. Horváth, P. Barnes, S. Kharitonov, 2004, Respiration.

Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia

P. Barnes, S. Kharitonov, R. Wilson, 2003, European Respiratory Journal.

Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects

K. Chung, P. Barnes, J. Nightingale, 1998, Thorax.

Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study

A. Nicholson, P. Barnes, S. Kharitonov, 2006, Respiratory research.

Exhaled carbon monoxide in lung disease

S. Kharitonov, P. Paredi, P. J. Barnes, 2003, European Respiratory Journal.

Measurement of Bronchial and Alveolar Nitric Oxide Production in Normal and Asthmatic Children

S. Kharitonov, A. Bush, C. Brindicci, 2006 .

Assessment of reproducibility of exhaled hydrogen peroxide concentration and the effect of breathing pattern in healthy subjects.

I. Horváth, P. Barnes, B. Antus, 2011, Journal of aerosol medicine and pulmonary drug delivery.

Adenosine 5'-monophosphate increases levels of leukotrienes in breath condensate in asthma.

K. Chung, P. Barnes, S. Kharitonov, 2004, Respiratory medicine.

Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma.

P. Barnes, S. Kharitonov, S. Shahid, 2002, American journal of respiratory and critical care medicine.

Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease

P. Barnes, S. Kharitonov, A. Papi, 2003, European Respiratory Journal.

Exhaled nitric oxide in chronic obstructive pulmonary disease.

W. Maziak, P. Barnes, S. Kharitonov, 1998, American journal of respiratory and critical care medicine.

Thrombolysis for submassive pulmonary embolism

I. Horváth, P. Barnes, S. Kharitonov, 2003, Thorax.

Effect of arginine on mucociliary function in primary ciliary dyskinesia

P. Barnes, S. Kharitonov, S. Loukides, 1998, The Lancet.

The effect of alcohol ingestion on exhaled nitric oxide.

D. Yates, P. Barnes, S. Kharitonov, 1996, European Respiratory Journal.

The acute effect of swimming on airway inflammation in adolescent elite swimmers.

V. Backer, P. Barnes, S. Kharitonov, 2009, The Journal of allergy and clinical immunology.

Increased Vitronectin and Endothelin-1 in the Breath Condensate of Patients with Fibrosing Lung Disease

R. D. du Bois, P. Barnes, G. E. Carpagnano, 2003, Respiration.

Faster rise of exhaled breath temperature in asthma: a novel marker of airway inflammation?

P. Barnes, S. Kharitonov, P. Paredi, 2002, American journal of respiratory and critical care medicine.

Exhaled breath temperature in asthma

P. Barnes, S. Kharitonov, P. Paredi, 2003, European Respiratory Journal.

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

P. Barnes, S. Kharitonov, K. Alving, 1997, The European respiratory journal.

exhaled nitric oxide : a marker of airway inflammation?

P. Barnes, S. Kharitonov, 1996 .

Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress

P. Barnes, S. Kharitonov, L. Donnelly, 1998, Thorax.

Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease.

P. Barnes, S. Kharitonov, P. Paredi, 2000, American journal of respiratory and critical care medicine.

Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids

S. Durham, K. Chung, P. Barnes, 1998, Thorax.

EXHALED NITRIC OXIDE IN MONITORING ASTHMA

P. Barnes, S. Kharitonov, 1997 .

Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress

I. Horváth, P. Barnes, S. Kharitonov, 1998, Thorax.

Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease?

P. Barnes, S. Kharitonov, P. Paredi, 1999, Chest.

Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients.

P. Barnes, O. Resta, G. E. Carpagnano, 2002, Chest.

Clinical aspects of exhaled nitric oxide.

P. Barnes, S. Kharitonov, 2000, The European respiratory journal.

High levels of interleukin-6 in the exhaled breath condensate of patients with COPD.

P. Barnes, S. Kharitonov, L. Allegra, 2003, Respiratory medicine.

Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma.

I. Horváth, P. Barnes, S. Kharitonov, 1999, The European respiratory journal.

Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine.

Sergei Kharitonov, Kazuhiro Ito, Caterina Brindicci, 2009, Chest.

Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide.

P. Montuschi, P. Barnes, J. Nightingale, 2002, Free radical biology & medicine.

Effects of Aerosolized Adenosine 5'-Triphosphate in Smokers and Patients With COPD.

P. Barnes, S. Kharitonov, O. Basoglu, 2015, Chest.

Increased nitric oxide in exhaled air of asthmatic patients

P. J. Barnes, D. Yates, P. Barnes, 1994, The Lancet.

Direct methods for the measurement of nitric oxide.

P. Barnes, S. Kharitonov, P. Paredi, 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Exhaled markers of pulmonary disease.

P. Barnes, S. Kharitonov, S A Kharitonov, 2001, American journal of respiratory and critical care medicine.

Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis.

P. Shah, P. Barnes, S. Kharitonov, 2001, The European respiratory journal.

Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype.

P. Barnes, S. Kharitonov, M. Hodson, 2000, Chest.

8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy.

Onofrio Resta, Giovanna E Carpagnano, P. Barnes, 2003, Chest.

Elevated levels of exhaled nitric oxide in bronchiectasis.

D M Hansell, D. Hansell, P. Barnes, 1995, American journal of respiratory and critical care medicine.

Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD

P. Barnes, S. Kharitonov, W. Biernacki, 2003, Thorax.

A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics

M. Currie, S. Kharitonov, L. Donnelly, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Religious and Spiritual Biomarkers in Both Health and Disease

S. Kharitonov, 2012 .

L-arginine increases exhaled nitric oxide in normal human subjects.

M. Hjelm, P. Barnes, S. Kharitonov, 1995, Clinical science.

Osteoprotegerin in sputum is a potential biomarker in COPD.

P. Barnes, S. Kharitonov, M. To, 2011, Chest.

ULTRA-LOW CONCENTRATIONS OF BENZIMIDAZOLE DERIVATIVES CAN INCREASE BULL AND HORSE SEMEN RESISTANCE AT CRYOPRESERVATION AND UNDER THE INFLUENCE OF DAMAGING FACTORS

S. Kharitonov, K. Plemyashov, E. Nikitkina, 2017 .

Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?

P. Barnes, G. E. Carpagnano, S. Kharitonov, 2004, Chest.

Local Vasodilator Response to Mobile Phones

S. Kharitonov, P. Paredi, P Paredi, 2001, The Laryngoscope.

Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers.

N. Lazzeri, P. Montuschi, P. Barnes, 2000, American journal of respiratory and critical care medicine.

Acute and chronic effects of cigarette smoking on exhaled nitric oxide.

D. Yates, P. Barnes, V. Keatings, 1995, American journal of respiratory and critical care medicine.

Exhaled nitric oxide: a new lung function test.

P. Barnes, S. Kharitonov, S A Kharitonov, 1996, Thorax.

Evaluation of new drugs for asthma and COPD: Endpoints, biomarkers and clinical trial designs

P. Barnes, S. Kharitonov, E. Erin, 2004 .

Biomarkers of some pulmonary diseases in exhaled breath

P. Barnes, S. Kharitonov, Peter J Barnes, 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Exhaled and nasal nitric oxide measurements : recommendations

S. Kharitonov, T. Higenbottam, T. Lundberg, 1997 .

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

P. Montuschi, P. Barnes, G. Ciabattoni, 2005, Thorax.

Increased nitrotyrosine in exhaled breath condensate of patients with asthma.

P. Barnes, S. Kharitonov, S A Kharitonov, 2000, American journal of respiratory and critical care medicine.

Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease.

P. Barnes, J. Hogg, S. Kharitonov, 2010, American journal of respiratory and critical care medicine.

Exhaled nitric oxide from lung periphery is increased in COPD

N. Pride, P. Barnes, O. Resta, 2005, European Respiratory Journal.

Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation

P. Barnes, O. Resta, G. E. Carpagnano, 2004, Thorax.

A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9

P. Elliott, J. Hogg, C. Rossios, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A novel approach to partition central and peripheral airway nitric oxide.

O. Usmani, P. Barnes, S. Kharitonov, 2014, Chest.

Exhaled markers of inflammatory lung diseases: ready for routine monitoring?

S. Kharitonov, Sergei A Kharitonov, 2004, Swiss medical weekly.

Elevation of exhaled ethane concentration in asthma.

P. Barnes, S. Kharitonov, P. Paredi, 2000, American journal of respiratory and critical care medicine.

Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma.

I. Horváth, K. Chung, P. Barnes, 1998, American journal of respiratory and critical care medicine.

Effect of inhaled l-arginine on exhaled nitric oxide in normal and asthmatic subjects

I. Horváth, K. Chung, P. Barnes, 1998, Thorax.

E V ect of inhaled L -arginine on exhaled nitric oxide in normal and asthmatic subjects

K. Chung, P. Barnes, S. Kharitonov, 1998 .

ect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects

I. Horváth, K. Chung, P. Barnes, 1998 .

8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases.

P. Montuschi, R. D. du Bois, P. Barnes, 1998, American journal of respiratory and critical care medicine.

Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.

P. Montuschi, P. Barnes, M. Corradi, 2001, American journal of respiratory and critical care medicine.

Disease Markers in Exhaled Breath

Magdi H. Yacoub, Peter J. Barnes, M. Yacoub, 2002 .

Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations.

S. Kharitonov, U. Sjöbring, 2007, Contributions to microbiology.

Real-time measurement of particulate matter deposition in the lung

P. Barnes, S. Kharitonov, P. Paredi, 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Contrasting effects of ATP and adenosine on capsaicin challenge in asthmatic patients.

P. Barnes, S. Kharitonov, O. Basoglu, 2017, Pulmonary pharmacology & therapeutics.

exhaled nitric oxide : a marker of airway inflammation?

P. Barnes, S. Kharitonov, D. R. Taylor, 1996 .

Inflammatory Markers: Exhaled Nitric Oxide and Carbon Monoxide During the Ovarian Cycle

P. Barnes, S. Kharitonov, A. Antczak, 2011, Inflammation.

Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke

S. Kharitonov, L. Donnelly, B. Bálint, 2001, Thorax.

Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.

P. Barnes, S. Kharitonov, A. Jatakanon, 1998, Thorax.

Exhaled and nasal nitric oxide measurements : recommendations

S. Kharitonov, T. Higenbottam, T. Lundberg, 1997 .

CHRONIC OBSTRUCTIVE PULMONARY DISEASE Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

P. Montuschi, P. Barnes, S. Kharitonov, 2005 .

CT-guided pleural biopsy preferable to traditional Abram’s needle in diagnosing malignant pleural disease

P. Montuschi, P. Barnes, S. Kharitonov, 2003, Thorax.

Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects

J. Nightingale, S. Kharitonov, L. Hart, 1998, Thorax.

Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation

G. E. Carpagnano, M. P. Foschino-Barbaro, S. Kharitonov, 2004, Thorax.

Thrombolysis for submassive pulmonary embolism

T. Seemungal, I. Horváth, P. Barnes, 2003, Thorax.